erythrosine has been researched along with naproxen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurtzhals, P; Larsen, C | 1 |
| Asselin, I; Célestin, F; Entman, M; Goulet, M; Guérette, B; Huard, C; Roy, B; Roy, R; Skuk, D; Tardif, F; Tremblay, JP | 1 |
| Brandl, M; Flaten, GE; Luthman, K; Skar, M | 1 |
| Brandl, M; Flaten, GE; Luthman, K; Vasskog, T | 1 |
4 other study(ies) available for erythrosine and naproxen
| Article | Year |
|---|---|
Preliminary studies on the in vivo fate of FITC-dextrans and naproxen-dextran ester prodrugs administered i.v. to rabbits.
Topics: Animals; Dextrans; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Injections, Intravenous; Male; Naproxen; Prodrugs; Rabbits | 1989 |
Prevention by anti-LFA-1 of acute myoblast death following transplantation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; beta-Galactosidase; Biomarkers; Cell Adhesion; Cell Death; Cell Line, Transformed; Fluoresceins; Genes, Reporter; Graft Rejection; Immunosuppressive Agents; Inflammation; Interleukin-1; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, SCID; Muscle, Skeletal; Muscular Dystrophy, Animal; Naproxen; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; Piroxicam; Radiation Chimera; Stem Cell Transplantation; Tacrolimus; Whole-Body Irradiation; Zymosan | 1997 |
Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Electric Impedance; Fluoresceins; Lipid Bilayers; Membranes, Artificial; Naproxen; Permeability; Pharmaceutical Preparations; Phosphatidylcholines; Phospholipids; Spectrophotometry, Ultraviolet; Sulfasalazine; Thermodynamics | 2007 |
Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.
Topics: Caco-2 Cells; Chemical Phenomena; Chemistry, Physical; Electric Impedance; Fluoresceins; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Naproxen; Permeability; Phospholipids; Solvents; Surface-Active Agents; Testosterone | 2008 |